Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer

類似資料

• Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
  著者:: Bepler, Gerold, 等
  出版事項: (2013)
• Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer
  著者:: Bepler, Gerold, 等
  出版事項: (2008)
• Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer
  著者:: Saito, Takeshi, 等
  出版事項: (2017)
• Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
  著者:: Muranaka, Tetsuhito, 等
  出版事項: (2017)
• Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients with Locally Advanced Carcinoma of the Bladder
  著者:: Smith, David C., 等
  出版事項: (2008)